Acceleron Pharma Company Profile

Aggregated data from the web about Acceleron Pharma

Company Name	Acceleron Pharma
Website	https://acceleronpharma.com
Snippet	Effective November 19, 2021, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada)
Founded	2003
Revenue	$74.5 million [1] for FY2017[2]
Website	acceleronpharma.com
Industry	Biotechnology
Traded as	NASDAQ: XLRNRussell 2000 Component
Key people	Habib Dable (CEO), Steve Ertel (COO), Matt Sherman (CMO), Kevin McLaughlin (CFO), Francois Nader (Chairman)
Headquarters	Cambridge, Massachusetts, United States
Number of employees	225 (Dec 2019)

Acceleron Pharma is part of the United States company list

Acceleron Pharma is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.